CYTOKINETICS INC Net Cash Provided by (Used in) Financing Activities in USD from 2010 to Q1 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Cytokinetics Inc quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2010 to Q1 2025.
  • Cytokinetics Inc Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2025 was $4.75M, a 95.4% decline year-over-year.
  • Cytokinetics Inc annual Net Cash Provided by (Used in) Financing Activities for 2024 was $931M, a 320% increase from 2023.
  • Cytokinetics Inc annual Net Cash Provided by (Used in) Financing Activities for 2023 was $221M, a 57.1% decline from 2022.
  • Cytokinetics Inc annual Net Cash Provided by (Used in) Financing Activities for 2022 was $516M, a 61.3% increase from 2021.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)

CYTOKINETICS INC Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2025 $4.75M -$99M -95.4% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-06
Q1 2024 $104M +$111M Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-06
Q1 2023 -$7.18M -$101M -108% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q1 2022 $93.8M +$97.4M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-05
Q1 2021 -$3.6M -$3.59M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q1 2020 -$11K* -$4.43M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q1 2019 $4.42M +$4.94M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q1 2018 -$524K Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
Q1 2014 $39.8M +$39.8M Jan 1, 2014 Mar 31, 2014 10-Q 2014-05-07
Q1 2013 $5K* -$2.66M Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-07
Q1 2012 $2.67M +$2.92M Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-08
Q1 2011 -$253K Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-04

CYTOKINETICS INC Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $931M +$709M +320% Jan 1, 2024 Dec 31, 2024 10-K 2025-02-27
2023 $221M -$295M -57.1% Jan 1, 2023 Dec 31, 2023 10-K 2025-02-27
2022 $516M +$196M +61.3% Jan 1, 2022 Dec 31, 2022 10-K 2025-02-27
2021 $320M +$85.9M +36.7% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 $234M +$74.3M +46.5% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-01
2019 $160M +$147M +1117% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-25
2018 $13.1M -$213M -94.2% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-26
2017 $226M Jan 1, 2017 Dec 31, 2017 10-K 2019-03-07
2013 $14.5M -$43.8M -75.2% Jan 1, 2013 Dec 31, 2013 10-K 2014-03-07
2012 $58.3M +$36.7M +170% Jan 1, 2012 Dec 31, 2012 10-K 2014-03-07
2011 $21.6M +$19.1M +749% Jan 1, 2011 Dec 31, 2011 10-K 2014-03-07
2010 $2.55M Jan 1, 2010 Dec 31, 2010 10-K 2013-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.